DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Masi G. et al.
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.
Ann Oncol 2015;
26: 724-730
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.